Abstract
Other factors such as burden of disease, magnitude of effect, current use, demand, equity and ease of integration must also be considered. Although less information was available about how to make explicit recommendations when there is insufficient evidence, the existing guidelines were adequate to develop a decision matrix for use in the IM setting. Conclusion: The proposed IM decision matrix facilitates the direct comparison of otherwise diverse therapies, often using different research methods of variable quality to support their use. It offers pragmatic solutions formaking specific recommendations about how best to integrate a T&CM intervention even when there is insufficient scientific evidence. Contact: Jennifer Hunter, jennifer.hunter@uws.edu.au
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
